Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Kenorland Minerals Receives Exercise Notices and Commitments from Strategic Investors
-
Torrent Capital Reports Final Q3 2026 Financial Results and Net Asset Value
-
Dryden Gold's CEO Issues Letter to Shareholders
-
Purpose Investments Adds an Active Equity Fund to the Purpose Active Suite (TSX: PAEF)
-
Condor Production Surpasses 18,500 boe/d as the 2026 Multi-Well Drilling Program Continues to Outperform
-
BioCryst Reports Third Quarter 2026 Financial Results
-
Biora Therapeutics Receives Approval for First-in-Human Trial of BioJet™ Oral Biologic Delivery Capsule
-
Qarakal Quantum to Deliver Keynote Presentation at World Quantum Cannes Festival
-
Aya Gold & Silver Drill Results Confirm High-Grade Continuity at Boumadine; New Permits Secured
-
Viridian Therapeutics Reports Third Quarter 2026 Financial Results and Highlights Recent Business Progress
-
Canfor reports results for the third quarter of 2026
-
The Kraft Heinz Company Declares Regular Quarterly Dividend of $0.40 Per Share
-
Criteo Expands Performance CTV Capabilities Across Global Markets
-
Capra Bank and Zact Expand Partnership to Drive Commercial Banking Growth
-
Shoals Technologies Group, Inc. Reports Financial Results for Third Quarter 2026
-
ARRAY Technologies Reports Financial Results for the Third Quarter 2026
-
Rocky Shore Initiates Exploration at Rocky Pond; Drilling Planned for Q1 2027
-
First Canadian Graphite Inc. Closes Flow-Through Financing
-
November 2026 Letter to Shareholders
-
Global Compliance Applications Corp. Corporate Update on Strategic Initiatives, Partnerships, Product Development, Closes 2nd Tranche of Private Placement and Announces New Financing
-
Wedgewood Weddings Expands to Maryland With Grey Rock Mansion
-
Jumia to Announce Third Quarter 2026 Results on November 18, 2026
-
Radiopharm Theranostics Announces Alignment with U.S. FDA on Single Pivotal Phase 3 Trial for RAD101 in Diagnosis of Brain Metastases
-
Yellow Card Acquires GoMoney, Establishing Direct Operations in Brazil
-
Nuvectis Pharma Reports Third Quarter 2026 Financial Results and Business Highlights
-
Phoenix Metals Strengthens Executive Team With Addition of Veteran CFO
-
CRITEO REPORTS THIRD QUARTER 2026 RESULTS
-
Bruker Reports Third Quarter 2026 Financial Results
-
Relmada Therapeutics to Participate at the Jefferies Global Healthcare Conference in London
-
McDONALD'S REPORTS THIRD QUARTER 2026 RESULTS
-
Schryver & Co. Serves as Exclusive M&A Advisor to Bee & Jay Plumbing & Heating in Its Successful Sale to a Local Entrepreneur
-
Cushman & Wakefield Reports Financial Results for the Third Quarter 2026
-
Brink's Delivers Strong Third-Quarter Results
-
RESERVOIR MEDIA ANNOUNCES SECOND QUARTER FISCAL 2027 RESULTS
-
CDW Reports Third Quarter 2026 Earnings
-
Tonix Pharmaceuticals to Present at Guggenheim’s 3rd Annual Healthcare Innovation Conference
-
CPI Reports Record Third Quarter 2026 Results
-
Marriott Vacations Worldwide Reports Third Quarter 2026 Financial Results
-
Six Flags expands the holiday cheer with more parks, more events and more ways for families to celebrate in 2026
-
ST Engineering iDirect, KT SAT, Waldo and Intellian Selected to Advance Secure Maritime Connectivity for South Korean Government Project
-
KYNDRYL REPORTS SECOND QUARTER FISCAL 2027 RESULTS
-
Arcline-Backed Signia Aerospace to Acquire Heads Up Technologies, Expanding Aircraft Cabin Systems Capabilities
-
Seres Therapeutics Reports Third Quarter 2026 Financial Results and Announces Plans for Advancing Development of SER-155 To Prevent Immune Checkpoint Inhibitor-Related Enterocolitis (irEC)
-
Solnul® Reproduces Clinical Outcomes, Strengthening Confidence in the Prebiotic Ingredient's Ability to Enhance the Microbiome and Support Digestive Comfort
-
Insulet Reports Third Quarter 2026 Results
-
SharkNinja Reports Third Quarter 2026 Results
-
Aircastle Announces Transition from Voluntary SEC Reporting
-
Charles River Laboratories Announces Third-Quarter 2026 Results
-
Operation Healing Forces Celebrates 15 Years of Impact with $15,000 Matching Gift Campaign Supported by Raymond James
-
Genprex Announces New Research Identifying TROP2 as a Potential Predictive Biomarker to Reqorsa® Gene Therapy in Lung Cancer


